PharmChem, Inc. (PCHM)
OTCMKTS
· Delayed Price · Currency is USD
3.000
0.00 (0.00%)
At close: Apr 25, 2025
PharmChem Revenue
PharmChem had revenue of $5.61M in the quarter ending March 31, 2004, a decrease of -11.51%. This brings the company's revenue in the last twelve months to $25.73M, down -11.12% year-over-year. In the year 2003, PharmChem had annual revenue of $26.46M, down -12.07%.
Revenue (ttm)
25.73M
Revenue Growth
-11.12%
P/S Ratio
0.54
Revenue / Employee
151.33K
Employees
170
Market Cap
13.94M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2003 | 26.46M | -3.63M | -12.07% |
| Dec 31, 2002 | 30.09M | -6.48M | -17.72% |
| Dec 31, 2001 | 36.57M | -2.83M | -7.18% |
| Dec 31, 2000 | 39.39M | -5.09M | -11.45% |
| Dec 31, 1999 | 44.49M | 1.32M | 3.05% |
| Dec 31, 1998 | Pro | Pro | Pro |
| Dec 31, 1997 | Pro | Pro | Pro |
| Dec 31, 1996 | Pro | Pro | Pro |
| Dec 31, 1995 | Pro | Pro | Pro |
| Dec 31, 1994 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 200.90M |
| Elite Pharmaceuticals | 70.00M |
| Northwest Biotherapeutics | 1.38M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 43.26M |
PharmChem News
- 2 months ago - PharmChem, Inc. Announces Exploration of Strategic Alternatives - PRNewsWire
- 3 years ago - PharmChem, Inc. Announces Tender Offer - Business Wire